TON - October 2020, Vol 13, No 5

TON June 2020, Vol 13, No 3 Cover

From The Editor TON October 2020
I was very honored to be asked to take the reins as the new Editor-in-Chief of The Oncology Nurse-APN/PA (TON) by the founding Editor-in-Chief Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN. Although Beth will be a hard act to follow, I will do my best to maintain the high standards she has established for the journal Read More ›

The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) in Baltimore is a National Cancer Institute–designated comprehensive cancer center, a distinction that places it in the top tier of cancer institutions in the United States. Read More ›

During the COVID-19 pandemic, oncology nurses have been the cornerstone of healthcare services, whether they are on the front lines offering compassionate care or in a leadership role developing and implementing new policies to promote better patient outcomes. Read More ›

Results from 2 studies highlight the increasingly important role of germline testing in the management of patients with cancer. These findings were presented by Zsofia K. Stadler, MD, Medical Oncologist, Clinical Genetics Service, Memorial Sloan Kettering Cancer Center, New York City. Read More ›

Impact of COVID-19 on Cancer Screening and How We Can Get Back on Track
For decades, healthcare professionals have worked diligently to teach individuals that screening is a valuable tool for preventing and detecting cancer. This has not been an easy mission, and nurses and physicians have had to debunk the myths, bias, and misinformation that deter patients from getting screened annually or according to specific guidelines set forth by organizations such as the Centers for Disease Control and Prevention (CDC) and the American Cancer Society (ACS). Read More ›

Until the late 1930s, stomach cancer—also called gastric cancer—was the leading cause of cancer death in the United States. Although stomach cancer is still a major cause of cancer-related deaths worldwide, it is now much less common in this country. The following provides a brief look at some of the key statistics regarding this disease. Read More ›

  • Selpercatinib Shows Durable Responses in Patients with Thyroid Cancer and RET Mutation
  • Venclexta plus Azacitidine Improves Overall Survival in Patients with AML
  • Advances in New Therapies Attributed to Reductions in Lung Cancer Mortality
Read More ›

Cancer health disparities remain a challenge in the United States, despite some strides being made to reduce these disparities, according to a new report from the American Association for Cancer Research (AACR) that was released in a virtual presentation on September 16, 2020. Read More ›

“COVID-19 is more than just the common cold. It represents a perpetual challenge for which we have to be perpetually prepared,” stated Anthony S. Fauci, MD, Director of the National Institute of Allergy and Infectious Diseases (NIAD), in his keynote lecture at the July 2020 AACR virtual meeting on COVID-19 and cancer. Read More ›

During the July 2020 AACR virtual meeting on COVID-19 and cancer, Solange Peters, MD, PhD, European Society for Medical Oncology President, and Head, Medical Oncology Department, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland, delivered the keynote address, providing an update on the COVID-19 and Cancer Consortium cohort study. Read More ›

Page 1 of 2


Subscribe to The Oncology Nurse-APN/PA

To sign up for our newsletter or print publications, enter your contact information below.

I'd like to receive: